U.S. IPO Weekly Recap: Biotech Leads Short Week

This Week in IPOs: A Mixed Bag of Debuts and Plans

This past week witnessed a flurry of activity in the initial public offering (IPO) space, encompassing a diverse range of companies from Phase 1 oncology biotech to Australian fitness programs, and even the sole appearance of a Special Purpose Acquisition Company (SPAC). However, the journey from IPO to market reality proved challenging for some, with notable downturns in their stock performance right out of the gate.